Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Oct;45(10):858–864. doi: 10.1136/ard.45.10.858

Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in vitro growth rates.

H M Burt, Y C Dutt
PMCID: PMC1002009  PMID: 3098195

Abstract

The effects of cartilage and synovial fluid components such as proteoglycans, chondroitin sulphate, hyaluronic acid, phospholipids, and albumin on the growth kinetics of monosodium urate monohydrate (MSUM) crystals were investigated. MSUM seed crystals were added to supersaturated sodium urate solutions, and the rate of decrease in the concentration of growth medium was used as a measure of the growth rate. A second order dependence of growth rate on supersaturation was found, and growth rate constants were determined with an integrated form of the growth equation. The additives, hyaluronic acid, proteoglycan monomer and aggregate, and phosphatidylserine, had no significant effect on the growth rate constant. Chondroitin sulphate and phosphatidylcholine increased the growth rate constant, possibly by promoting further nucleation in the growth medium. Albumin significantly inhibited MSUM crystallisation. The possible implications of these findings on in vivo MSUM crystallisation are discussed.

Full text

PDF
862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen D. J., Milosovich G., Mattocks A. M. Inhibition of monosodium urate needle crystal growth. Arthritis Rheum. 1965 Dec;8(6):1123–1133. doi: 10.1002/art.1780080611. [DOI] [PubMed] [Google Scholar]
  2. BOLE G. G. Synovial fluid lipids in normal individuals and patients with rheumatoid arthritis. Arthritis Rheum. 1962 Dec;5:589–601. doi: 10.1002/art.1780050606. [DOI] [PubMed] [Google Scholar]
  3. Barker S. A., Hawkins C. F., Hewins M. Mucopolysaccharides in synovial fluid detection of chondroitin sulphate. Ann Rheum Dis. 1966 May;25(3):209–213. doi: 10.1136/ard.25.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bjelle A. Cartilage matrix in hereditary pyrophosphate arthropathy. J Rheumatol. 1981 Nov-Dec;8(6):959–964. [PubMed] [Google Scholar]
  5. Blumenthal N. C., Posner A. S., Silverman L. D., Rosenberg L. C. Effect of proteoglycans on in vitro hydroxyapatite formation. Calcif Tissue Int. 1979 Mar 13;27(1):75–82. doi: 10.1007/BF02441164. [DOI] [PubMed] [Google Scholar]
  6. Bonner W. M., Jonsson H., Malanos C., Bryant M. Changes in the lipids of human articular cartilage with age. Arthritis Rheum. 1975 Sep-Oct;18(5):461–473. doi: 10.1002/art.1780180505. [DOI] [PubMed] [Google Scholar]
  7. Burt H. M., Kalkman P. H., Mauldin D. Membranolytic effects of crystalline monosodium urate monohydrate. J Rheumatol. 1983 Jun;10(3):440–448. [PubMed] [Google Scholar]
  8. CHUNG A. C., SHANAHAN J. R., BROWN E. M., Jr Synovial fluid lipids in rheumatoid and osteoarthritis. Arthritis Rheum. 1962 Apr;5:176–183. doi: 10.1002/art.1780050206. [DOI] [PubMed] [Google Scholar]
  9. Denko C. W., Whitehouse M. W. Experimental inflammation induced by naturally occurring microcrystalline calcium salts. J Rheumatol. 1976 Mar;3(1):54–62. [PubMed] [Google Scholar]
  10. Fiddis R. W., Vlachos N., Calvert P. D. Studies of urate crystallisation in relation to gout. Ann Rheum Dis. 1983 Aug;42 (Suppl 1):12–15. doi: 10.1136/ard.42.suppl_1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kaufman R. L., Glenn W. V., Jr Rheumatoid cervical myelopathy: evaluation by computerized tomography with multiplanar reconstruction. J Rheumatol. 1983 Feb;10(1):42–54. [PubMed] [Google Scholar]
  12. LAURENT T. C. SOLUBILITY OF SODIUM URATE IN THE PRESENCE OF CHONDROITIN-4-SULPHATE. Nature. 1964 Jun 27;202:1334–1334. doi: 10.1038/2021334a0. [DOI] [PubMed] [Google Scholar]
  13. Loeb J. N. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972 Mar-Apr;15(2):189–192. doi: 10.1002/art.1780150209. [DOI] [PubMed] [Google Scholar]
  14. Maroudas A. Glycosaminoglycan turn-over in articular cartilage. Philos Trans R Soc Lond B Biol Sci. 1975 Jul 17;271(912):293–313. doi: 10.1098/rstb.1975.0054. [DOI] [PubMed] [Google Scholar]
  15. Perricone E., Brandt K. D. Enhancement of urate solubility by connective tissue. I. Effect of proteoglycan aggregates and buffer cation. Arthritis Rheum. 1978 May;21(4):453–460. doi: 10.1002/art.1780210409. [DOI] [PubMed] [Google Scholar]
  16. Simkin P. A., Campbell P. M., Larson E. B. Gout in Heberden's nodes. Arthritis Rheum. 1983 Jan;26(1):94–97. doi: 10.1002/art.1780260116. [DOI] [PubMed] [Google Scholar]
  17. Tak H. K., Cooper S. M., Wilcox W. R. Studies on the nucleation of monosodium urate at 37 degrees c. Arthritis Rheum. 1980 May;23(5):574–580. doi: 10.1002/art.1780230509. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES